Annual Shareholders Equity
$13.24 M
-$17.31 M-56.66%
31 December 2023
Summary:
FSD Pharma annual stockholders equity is currently $13.24 million, with the most recent change of -$17.31 million (-56.66%) on 31 December 2023. During the last 3 years, it has fallen by -$23.07 million (-63.54%).HUGE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$10.96 M
-$1.07 M-8.91%
30 June 2024
Summary:
FSD Pharma quarterly stockholders equity is currently $10.96 million, with the most recent change of -$1.07 million (-8.91%) on 30 June 2024. Over the past year, it has dropped by -$3.88 million (-26.14%).HUGE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUGE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.7% | -26.1% |
| 3 y3 years | -63.5% | -81.8% |
| 5 y5 years | -64.7% | -76.4% |
HUGE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -75.5% | -84.0% |
FSD Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $10.96 M(-8.9%) |
| Mar 2024 | - | $12.03 M(-9.1%) |
| Dec 2023 | $13.24 M(-56.7%) | $13.24 M(-10.8%) |
| Sept 2023 | - | $14.84 M(-4.6%) |
| June 2023 | - | $15.55 M(-25.4%) |
| Mar 2023 | - | $20.86 M(-31.7%) |
| Dec 2022 | $30.54 M(-43.6%) | $30.54 M(-15.5%) |
| Sept 2022 | - | $36.14 M(-15.1%) |
| June 2022 | - | $42.58 M(-8.9%) |
| Mar 2022 | - | $46.76 M(-13.6%) |
| Dec 2021 | $54.13 M(+49.1%) | $54.13 M(-10.0%) |
| Sept 2021 | - | $60.15 M(+3.2%) |
| June 2021 | - | $58.28 M(-14.9%) |
| Mar 2021 | - | $68.51 M(+88.7%) |
| Dec 2020 | $36.31 M(+0.1%) | $36.31 M(+14.2%) |
| Sept 2020 | - | $31.80 M(-5.2%) |
| June 2020 | - | $33.55 M(+11.7%) |
| Mar 2020 | - | $30.04 M(-17.2%) |
| Dec 2019 | $36.28 M | $36.28 M(-21.8%) |
| Sept 2019 | - | $46.40 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $51.00 M(+37.6%) |
| Mar 2019 | - | $37.07 M(-1.1%) |
| Dec 2018 | $37.47 M(+279.5%) | $37.47 M(-27.0%) |
| Sept 2018 | - | $51.31 M(+28.6%) |
| June 2018 | - | $39.91 M(+292.3%) |
| Mar 2018 | - | $10.17 M(+490.8%) |
| Feb 2018 | - | $1.72 M(-2271.6%) |
| Dec 2017 | $9.87 M(<-9900.0%) | - |
| Nov 2017 | - | -$79.30 K(+4.8%) |
| Aug 2017 | - | -$75.70 K(+14.7%) |
| Aug 2017 | -$75.70 K(+39.4%) | - |
| May 2017 | - | -$66.00 K(+21.5%) |
| Aug 2016 | -$54.30 K(-7.0%) | -$54.30 K |
| Aug 2015 | -$58.40 K(-100.7%) | - |
| Dec 2014 | $8.08 M(+80.0%) | - |
| Dec 2013 | $4.49 M(+82.3%) | - |
| Dec 2012 | $2.46 M(+3.2%) | - |
| Dec 2011 | $2.39 M(+21.0%) | - |
| Dec 2010 | $1.97 M(-27.8%) | - |
| Dec 2009 | $2.73 M | - |
FAQ
- What is FSD Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for FSD Pharma?
- What is FSD Pharma annual shareholders equity year-on-year change?
- What is FSD Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for FSD Pharma?
- What is FSD Pharma quarterly shareholders equity year-on-year change?
What is FSD Pharma annual stockholders equity?
The current annual shareholders equity of HUGE is $13.24 M
What is the all time high annual shareholders equity for FSD Pharma?
FSD Pharma all-time high annual stockholders equity is $54.13 M
What is FSD Pharma annual shareholders equity year-on-year change?
Over the past year, HUGE annual stockholders equity has changed by -$17.31 M (-56.66%)
What is FSD Pharma quarterly stockholders equity?
The current quarterly shareholders equity of HUGE is $10.96 M
What is the all time high quarterly shareholders equity for FSD Pharma?
FSD Pharma all-time high quarterly stockholders equity is $68.51 M
What is FSD Pharma quarterly shareholders equity year-on-year change?
Over the past year, HUGE quarterly stockholders equity has changed by -$3.88 M (-26.14%)